Description The stent is characterized by flexible 'S' crowns and longitudinal 'V' crowns that cross each other in a unique junction which undergoes rotation during expansion. This unique expansion mechanism distributes stress and minimizes foreshortening and recoil. The stent has two radiopaque gold markers for visibility of the stent ends, allowing for precise positioning.
Abstract Information available in the literature concerning the composition of lipids in wheat germ and in wheat germ oil is critically reviewed. After a brief introduction to the botanical and technological aspects of wheat germ, the yield of oil and its physico‐chemical properties are described followed by the composition of fatty acids, acyl lipids and non‐saponifiable components. The importance of distinguishing between dissected germ and commercial wheat germ and between germ oil and germ lipids is emphasised. The triglycerides account for the major part of the fatty acids, of which linoleic acid is the principal component, and the content of free fatty acids depends on the rancidity of the germ and also on possible post‐extraction processing in the case of commercial oil. Polar lipids consist mainly of phospholipids and available information suggests that glycolipids are present only at very low concentration and that galactosyl glycerides may be absent from the embryo of the quiescent wheat grain. Most reports of tocopherol composition concern wheat germ oil and there is less information about the tocopherols of dissected wheat germ. α‐ and β‐tocopherols are found in wheat germ but tocotrienols are probably absent from dissected germ and only occur in commercial germ as a result of bran and endosperm contamination. Wheat germ oil exhibits a range of sterols. 4‐methyl sterols and triterpenoid alcohols, and β‐sitosterol and campesterol are the major components. The hydrocarbon composition of wheat germ oil has been reported but the significance of the results is uncertain. Flavonoid pigments, xanthophyll and xanthophyll esters have been shown to be present in wheat germ. Most of the studies of the non‐saponifiable fraction were based on germ oil and commercial wheat germ and little is known of the nature of this fraction in dissected wheat germ.
Platelet-activating factor (PAF) is a highly potent lipid mediator which has been implicated in inflammation and particularly in allergic inflammation, including asthma.1–3 It is released from many of the inflammatory cells which are known to be activated in asthma and has many inflammatory effects on airways. This has suggested that PAF antagonists might be useful in the therapy of asthma and other pulmonary inflammatory diseases.45 The purpose of this chapter is to review the potential role of PAF in inflammatory diseases of the airways, and to discuss the effects of recently developed PAF receptor antagonists.
AimsIncomplete endothelialization has been found to be associated with late stent thrombosis, a rare but devastating phenomenon, more frequent after drug-eluting stent implantation. Optical coherence tomography (OCT) has 10 times greater resolution than intravascular ultrasound and thus appears to be a valuable modality for the assessment of stent strut coverage. The LEADERS trial was a multi-centre, randomized comparison of a biolimus-eluting stent (BES) with biodegradable polymer with a sirolimus-eluting stent (SES) using a durable polymer. This study sought to evaluate tissue coverage and apposition of stents using OCT in a group of patients from the randomized LEADERS trial.